Skip to main content

PharmStars

By Jessica Hagen and Emily Olsen | 01:15 pm | December 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
By Emily Olsen | 03:24 pm | January 06, 2022
Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.
By Laura Lovett | 03:30 pm | December 13, 2021
The 10-week program was focused on clinical trial innovation. 
By Laura Lovett | 02:20 pm | June 01, 2021
PharmStars will be launching its 10-week accelerator in the fall.